Smoldering Multiple Myeloma (SMM)
Oncology·MeSH: Multiple Myeloma
Prevalence
30.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Smoldering Multiple Myeloma (SMM)?
There are 2 clinical trials targeting Smoldering Multiple Myeloma (SMM) tracked by BioSniper.
What is the prevalence of Smoldering Multiple Myeloma (SMM)?
The estimated prevalence of Smoldering Multiple Myeloma (SMM) is approximately 30.0 per 100,000 population.
Deep-dive into Smoldering Multiple Myeloma (SMM)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis